Research & Development

Excilone leverages its expertise in research and development of new technologies
to provide its customers with state-of-the-art sample analysis techniques.

Through our R&D initiatives, we aim to contribute to the acceleration of research work.
dedicated to the discovery of new biomarkers for complex diseases such as cancer.
Our commitment is to improve the early detection and diagnostic accuracy of these diseases.

Whether independently or in collaboration with renowned academic institutions,
our R&D teams develop innovative methods to reduce analysis scales.
This work opens up new possibilities for cellular and tissue exploration.

At the same time, we are reinforcing the traceability and efficiency of sample analyses
thanks to our dedicated team of software developers and engineers.